Stepping out of antiquity: An update on emerging... - MPN Voice

MPN Voice

10,341 members14,253 posts

Stepping out of antiquity: An update on emerging drugs for the treatment of polycythemia vera

Manouche profile image
2 Replies

Abstract

Introduction: Polycythemia vera is a chronic hematologic malignancy frequently presenting with constitutional symptoms and associated with an increased risk of thrombosis, hemorrhage, and progression to myelofibrosis or acute myeloid leukemia. Current treatment strategies reduce thrombohemorrhagic risk by controlling blood counts and inhibiting platelets, but often fail to address disease-relate symptoms or biologically modify the disease.

Areas covered: We review the current paradigm for treating polycythemia vera, highlight areas of unmet need, review therapeutic agents in late stage clinical development, and provide an overarching view of how these emerging agent may fit into the future armamentarium of polycythemia vera treatments.

Expert opinion: The shift from focusing solely on secondary prevention of thrombohemorrhagic events to a comprehensive treatment strategy that additionally aims to improve quality of life and prevent disease progression has resulted in a rapidly evolving therapeutic landscape that promises to move the treatment of polycythemia vera out of antiquity into the modern age.

pubmed.ncbi.nlm.nih.gov/341...

Written by
Manouche profile image
Manouche
To view profiles and participate in discussions please or .
2 Replies
Aldebaran25 profile image
Aldebaran25

Thanks for this. From the link it looks like at the moment only the abstract is available, unless I missed something.

lhammy66 profile image
lhammy66

Looks locked behind a paywall but will try on Monday to access through my uni- not sure if they have access to this journal or not but will try

You may also like...

Increased Besremi Dose to Be Studied for Polycythemia Vera Treatment

com/view/increased-besremi-dose-to-be-studied-for-polycythemia-vera-treatment

Ropeginterferon Alfa-2b listed as Preferred Treatment in Polycythemia Vera

as a preferred treatment option for patients with high- and low-risk polycythemia vera,...

Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management

influence treatment choices. The current review also includes specific treatment strategies in the...

Next Steps for Research With Interferon-Alpha in Polycythemia Vera

ps-for-research-with-interferon-alpha-in-polycythemia-vera

diagnosed with Polycythemia Vera

yesterday that I have been diagnosed with Polycythemia Vera . They said 20% of my bone marrow has...